Enhanced Efficacy of Post-Procedural Skin Care: A Double-Blind, Randomized, Vehicle-Controlled, Split-Face Clinical Study Assessing a Novel Neuropeptide Serum Following Botulinum Toxin Injection
Mark Lupin, Patricia Brieva, Nour R Dayeh, Stacy White · 2026
Read Enhanced Efficacy of Post-Procedural Skin Care: A Double-Blind, Randomized, Vehicle-Controlled, Split-Face Clinical Study Assessing a Novel Neuropeptide Serum Following Botulinum Toxin Injection by Mark Lupin, Patricia Brieva, Nour R Dayeh, Stacy White (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13265011.txt.
Description
Mark Lupin and co-authors present a 2026 split-face trial of a neuropeptide serum used around botulinum toxin injections, the wrinkle-relaxing shots widely used in cosmetic care. Each person applied the serum to one half of the face and a plain base to the other, before and after injections, so the comparison stayed within the same skin.
The study ran ten weeks, with injections for frown and eye-corner lines at the midpoint start. A blinded dermatologist graded 18 facial traits, and the serum side improved significantly more on traits like forehead wrinkles, fine lines, smoothness, and glow at eight weeks after injection. Gains appeared even before the injections, in the two weeks of serum use alone. No tolerance problems appeared. The authors conclude the serum enhances injection results.
Catalog record
| CREATOR | Mark Lupin, Patricia Brieva, Nour R Dayeh, Stacy White |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30558 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |